lansoprazole has been researched along with lafutidine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Mizuta, Y; Murase, K; Murata, I; Nishiyama, H; Omagari, K; Shikuwa, S | 1 |
| Anbo, T; Asaka, M; Fujinaga, A; Hagiwara, T; Imamura, A; Kato, M; Nakagawa, M; Nakagawa, S; Shimizu, Y; Suga, T; Takeda, H; Uchida, T; Yamamoto, J | 1 |
| Abe, Y; Akimoto, K; Akiyama, T; Fujita, K; Inamori, M; Kirikoshi, H; Kubota, K; Nakajima, A; Saito, S; Takahashi, H; Ueno, N; Yoneda, M | 1 |
| Goso, Y; Ichikawa, T; Ikezawa, T; Ishihara, K; Iwai, T; Nakano, M; Saegusa, Y; Saigenji, K; Shikama, N | 1 |
| Abe, Y; Goto, J; Hishinuma, T; Horii, T; Iijima, K; Imatani, A; Kikuchi, R; Kobayashi, S; Koike, T; Ohara, S; Shimosegawa, T; Suzuki, K; Yamagishi, H | 1 |
| Chae, HS; Chang, YW; Cho, CM; Chun, HJ; Chung, IS; Hong, SJ; Jeon, WJ; Jung, HC; Kim, HU; Kim, JG; Kim, JW; Kim, N; Kim, SW; Kim, TN; Lee, GH; Lee, KJ; Lee, OJ; Lee, SW; Park, CG; Park, CH; Park, JJ; Park, JY; Park, KS; Park, MI; Park, SH; Seo, GS; Seol, S; Shim, KN; Shin, JE; Shin, WC; Shin, YW; Song, GA; Won, SY; Yoon, BC | 1 |
| Haruma, K; Inoue, M; Kawano, S; Kinoshita, Y; Komatsu, H; Komazawa, Y; Kushiyama, Y; Manabe, N; Mukai, S; Nagata, S; Okada, H; Okanobu, H; Onogawa, S; Takenaka, R; Tanaka, S; Todo, H; Yoshinaga, F | 1 |
5 trial(s) available for lansoprazole and lafutidine
| Article | Year |
|---|---|
Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Piperidines; Prospective Studies; Pyridines | 2003 |
Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Piperidines; Pyridines | 2007 |
Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Administration, Oral; Adult; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Genotype; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Piperidines; Proton Pump Inhibitors; Pyridines | 2008 |
Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Lansoprazole; Male; Middle Aged; Piperidines; Pyridines; Time Factors; Treatment Outcome | 2008 |
Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Heartburn; Histamine H2 Antagonists; Humans; Japan; Lansoprazole; Male; Middle Aged; Piperidines; Proton Pump Inhibitors; Pyridines; Severity of Illness Index; Treatment Outcome | 2016 |
2 other study(ies) available for lansoprazole and lafutidine
| Article | Year |
|---|---|
Is oral combination therapy with a proton-pump inhibitor and H2 receptor antagonist effective as initial treatment?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Administration, Oral; Adult; Drug Therapy, Combination; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Piperidines; Proton Pump Inhibitors; Pyridines | 2007 |
Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Animals; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Fluorouracil; Gastric Mucosa; Gastrointestinal Diseases; Intestinal Mucosa; Lansoprazole; Male; Mucins; Mucositis; Omeprazole; Piperidines; Pyridines; Rats; Rats, Wistar | 2008 |